{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:11:55Z","timestamp":1791295915780,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/nm.4353","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T17:58:59Z","timestamp":1496771939000},"page":"656-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Understanding cancer from the stem cells up"],"prefix":"10.1038","volume":"23","author":[{"given":"Christopher A","family":"Eide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J","family":"Druker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"BFnm4353_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman, D.R. & Weinberg, R.A. Nat. Rev. Drug Discov. 13, 497\u2013512 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm4353_CR2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrc3368","volume":"12","author":"P Valent","year":"2012","unstructured":"Valent, P. et al. Nat. Rev. Cancer 12, 767\u2013775 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm4353_CR3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini, A. et al. Nat. Med. 23 692\u2013702 (2017).","journal-title":"Nat. Med."},{"key":"BFnm4353_CR4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","volume":"12","author":"T O'Hare","year":"2012","unstructured":"O'Hare, T., Zabriskie, M.S., Eiring, A.M. & Deininger, M.W. Nat. Rev. Cancer 12, 513\u2013526 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm4353_CR5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","volume":"376","author":"A Hochhaus","year":"2017","unstructured":"Hochhaus, A. et al. N. Engl. J. Med. 376, 917\u2013927 (2017).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4353_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin, A.S. et al. J. Clin. Invest. 121, 396\u2013409 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnm4353_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-017-0145-6","volume":"6","author":"DL Ellsworth","year":"2017","unstructured":"Ellsworth, D.L. et al. Clin. Transl. Med. 6, 15 (2017).","journal-title":"Clin. Transl. Med."},{"key":"BFnm4353_CR8","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1182\/blood-2016-07-728873","volume":"129","author":"R Warfvinge","year":"2017","unstructured":"Warfvinge, R. et al. Blood 129, 2384\u20132394 (2017).","journal-title":"Blood"},{"key":"BFnm4353_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L.M. Cancer Cell 21, 309\u2013322 (2012).","journal-title":"Cancer Cell"},{"key":"BFnm4353_CR10","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Nature 511, 543\u2013550 (2014).","DOI":"10.1038\/nature13385"},{"key":"BFnm4353_CR11","unstructured":"Cancer Genome Atlas Research N. Engl. J. Med. 368, 2059\u20132074 (2013)."},{"key":"BFnm4353_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.gde.2009.12.002","volume":"20","author":"S Maheswaran","year":"2010","unstructured":"Maheswaran, S. & Haber, D.A. Curr. Opin. Genet. Dev. 20, 96\u201399 (2010).","journal-title":"Curr. Opin. Genet. Dev."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4353","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nm.4353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:02:07Z","timestamp":1684450927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFnm4353"],"URL":"https:\/\/doi.org\/10.1038\/nm.4353","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"6 June 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.J.D. is currently principal investigator or co-investigator on Novartis and Bristol-Myers Squibb clinical trials. His institution, OHSU, has contracts with these companies to pay for patient costs, nurse and data-manager salaries, and institutional overhead. He does not derive a salary, and his lab does not receive funds from these contracts. OHSU and B.J.D. have a financial interest in MolecularMD, a company that may have a commercial interest in this research and technology. This potential individual and institutional conflict of interest has been reviewed and managed by OHSU.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}